Bayer Schering Pharma (Logo)
Bayer Heathcare (Logo)
  • Sitemap
  • RSS
  • Contact us
Home
  • Company
    • Our Biotech Leadership
    • Corporate Social Responsibility
  • Locations
    • Berkeley
    • Emeryville
    • Richmond
    • Seattle
  • Products
    • Bayer AG
    • About Betaseron®
    • About Kogenate®
    • About Leukine®
  • Research & Development
    • R&D Groups
    • Key Development Projects
  • Biomanufacturing
    • Berkeley
    • Emeryville
    • Seattle
  • Partnering
    • Opportunities
  • Careers
    • Current Openings
    • Employee Profiles
    • Benefits
    • Diversity
    • Internships
  • Newsroom
    • News
    • Media Contacts
    • RSS
  • Locations
  • Berkeley
  • Emeryville
    • Richmond
    • Seattle
    Country Links

    Bayer Links
    • Bayer Global
    • Bayer HealthCare Global
    • Investor Relations
    • General Conditions of Use
    • Privacy Statement
    • Imprint

    Copyright ©
    Bayer HealthCare

    Bayer HealthCare Pharmaceuticals in Emeryville, California

    The Emeryville Supply Center is the manufacturing center for Betaseron (Interferon beta-1b)*, along with three other proteins. The acquisition of the Emeryville Supply Center in September 2007 made Bayer the second largest biotech employer in the San Francisco Bay Area. Under the leadership of Olivia Krampe, the site operates 24 hours a day, seven days a week with approximately 600 employees.

    5650 Hollis Street
    P.O. Box 8803
    Emeryville, CA 94608
    (510) 597-6100

    * BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

    Important Safety Information
    The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.


    Emeryville building

    Learn more about:

    • Emeryville’s biomanufacturing
    • Betaseron and Multiple Sclerosis
    Font size
    -+ Font Sizer Control

    click to adjust

    Page tools
    • Printer friendly version
    • Bookmark this page
    • Email Us
    Search